Antidote Technologies raised €19M in a funding round in Jun 2021. The company is based in London, UK. Investors in the round: LBO France, Merck Global Health Innovation Fund, Octopus Ventures and 1 other. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
